InMode Aesthetic Solutions Expands Beauty Treatment Range With BodyTite

Cosmetic Industry Pioneers Deliver Surgical Results Without Scarring With Latest Technology


LAKE FOREST, Calif., April 06, 2017 (GLOBE NEWSWIRE) -- InMode Aesthetic Solutions®, a leader in aesthetic medicine and technology, is proud to announce the launch of the brand’s newest procedure, BodyTite. This non-excisional device utilizes radio-frequency assisted lipolysis (RFAL) to address the shortcomings often associated with traditional liposuction or surgical body and face lifts, including sagging or wrinkly skin and scarring, by inserting a wand under the skin to coagulate inside while tightening the skin on top.

With over one hundred surgical practices in North America already utilizing the new technology, doctors can ensure their patients receive surgical-like procedures with limited downtime and without scars. The FDA approved technology, for use on the stomach, arms, chest, knees and inner/outer thighs, is minimally invasive and leaves virtually no scarring. Results can be seen immediately after one treatment and are more evident over three to six months post-treatment. 

Previously, patients looking for fat reduction treatments had limited options including multiple non-invasive treatments with limited skin contraction results, a surgical tummy tuck with downtime or a brachioplasty, leaving large excision scars. These options left patients who wanted less invasive procedures without a solution, or unhappy with the results of their treatment. With BodyTite, doctors are able to ensure patients receive minimally invasive, effective procedures and offer powerful aesthetic results.

“Traditional surgery can leave permanent scars, and does not really fix the problem -- soft tissue with no internal support framework,” Diane Duncan, M.D., Fort Collins CO, a practitioner of BodyTite explains.  “This new device is providing that internal structure reorganization, and in addition, has been proven to create up to 36.4% skin surface area contraction at one year” (Duncan, Aesthetic Surgery Journal, 2016).

“BodyTite is one of many technological innovations to come from InMode this year,” says Erik Dowell, CEO of InMode North America. “With our enhanced management team, we are looking forward to showcasing the advances we are making to the cosmetic industry to doctors and patients alike.”

About InMode: InMode’s technological advancements have become the new standard for aesthetic medicine, specifically in the radio-frequency aesthetic market. For more than three decades our R&D team was critical in developing state-of-the-art light, laser and radio-frequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. Learn more about InMode technologies by visiting www.inmodemd.com.


            

Kontaktdaten